Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Shoji KimuraKeisuke ShigetaShingo TamuraKeita UchinoTakahiro KimuraYukinori OzakiHiroshi NishioKenji TsuchihashiEiki IchiharaMakoto EndoShingo YanoDai MaruyamaTetsuhiro YoshinamiNobuyuki SusumuMunetaka TakekumaTakashi MotohashiMamoru ItoEishi BabaNobuaki OchiToshio KuboYutaro KamiyamaShinji NakaoShinobu TamuraHitomi NishimotoYasuhisa KatoAtsushi SatoToshimi TakanoYuji MiuraPublished in: International journal of clinical oncology (2024)
G-CSF may be beneficial as primary prophylaxis during CBZ administration for metastatic castration resistant prostate cancer, and we made a "weak recommendation to perform" with an annotation of the relevant regimen.